Abstract:Background and objective Anaesthetic preconditioning (APC) protects against myocardial ischaemia/reperfusion injury. Nuclear factor-kappa B (NF-kappa B) has been implicated in APC-induced myocardial protection in vitro. Our study tested the hypothesis that in-vivo APC with sevoflurane is triggered by NF-kappa B through downregulation of inflammatory mediators and upregulation of antiapoptosis factors to prevent myocardial injury during ischaemia/reperfusion.Methods In this in-vivo study, rats were anaesthetized and maintained with sodium pentobarbital throughout the experiment. Rats were exposed to 30 min of 2.5% sevoflurane followed by 15 min washout (APC group) or no inhalation anaesthetics (ischaemia/reperfusion group) before ischaemia/reperfusion. In the sevoflurane group, rats were exposed to 30 min sevoflurane followed by a 165 min washout period. The NF-kappa B inhibitor parthenolide (PTN) was used before or after exposure to sevoflurane (PTN+APC group and APC+PTN group). Left ventricular samples were obtained to measure infarct size, pro-inflammation and apoptosis. A P value less than 0.05 was considered significant.Results APC reduced infarct size (34 +/- 6%) compared with ischaemia/reperfusion (53 +/- 6%, P < 0.05). PTN administered before or after APC abolished the cardioprotection (53 +/- 5 and 52 +/- 7%, respectively, P < 0.05). APC decreased the myocardium apoptosis compared with the ischaemia/reperfusion only group (6 +/- 1 vs. 19 +/- 3%, P < 0.05); PTN administered before or after sevoflurane preconditioning abolished this effect. APC induced upregulation of NF-kappa B p50/p65 before ischaemia (51 +/- 4/26 +/- 3% vs. 15 +/- 1/11 +/- 1% in the control group, P < 0.05). After reperfusion, NF-kappa B was upregulated in the ischaemia/reperfusion and APC groups, but it was lower in the APC group than in the ischaemia/reperfusion group. PTN administered before and after APC inhibited the expressions. Before ischaemia, Bcl-2 was increased in the APC and sevoflurane groups (94 +/- 3 and 102 +/- 4%, respectively) compared with the control group (68 +/- 2%, P < 0.05). After reperfusion, intercellular adhesion molecule-1, tumour necrosis factor-a and caspase-3 expressions were significantly increased in the ischaemia/reperfusion group (92 +/- 5, 115 +/- 4 and 65 +/- 2% compared with the control group, P < 0.05); these increases were blunted in the APC group.Conclusion APC with sevoflurane produced myocardial protection against ischaemia/reperfusion in vivo. NF-kappa B acted not only as a trigger but also as a mediator that played an important role in APC through upregulation of NF-kappa B and the antiapoptosis protein Bcl-2 during the preconditioning period and then through downregulation of the inflammatory proteins intercellular adhesion molecule-1 and tumour necrosis factor-alpha during reperfusion, ultimately decreasing caspase-3 expression and apoptosis. Eur J Anaesthesiol 2010; 27:747-756

Role of Nuclear Factor-Κb in Volatile Anaesthetic Preconditioning with Sevoflurane During Myocardial Ischaemia/reperfusion.

[Sevoflurane Postconditioning Attenuates Myocardial Apoptosis in Isolated Rat Hearts Via a Modulation of Bcl-2 Family Proteins].

Sevoflurane Postconditioning Reduces Myocardial Reperfusion Injury in Rat Isolated Hearts Via Activation of PI3K/Akt Signaling and Modulation of Bcl-2 Family Proteins.

Protection of NF - Κb Activation During Sevoflurane Preconditioning in Rat Model of Myocardial Ischemia - Reperfusion

Sevoflurane Preconditioning Confers Neuroprotection via Anti-apoptosis Effects

Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects.

Postconditioning of Sevoflurane and Propofol is Associated with Mitochondrial Permeability Transition Pore

NF-κB Participates the Process of Sevoflurane Preconditioning on Myocardium Against Ischemia-Reperfusion Injury in Rats

Postconditioning with Sevoflurane Protects Against Focal Cerebral Ischemia and Reperfusion Injury Via Pi3k/Akt Pathway

Effects of Sevoflurane Preconditioning on P-Iκbα in a Rat Model of Myocardial Ischemia-Reperfusion

NF-κB Participates in Sevoflurane Preconditioning Induced Delayed Type Protection Against Ischemia-Reperfusion Injury in Myocardium of Rats

Sevoflurane Post-Conditioning Reduces Rat Myocardial Ischemia Reperfusion Injury Through An Increase In Nos And A Decrease In Phopshorylated Nhe1 Levels

Effect of sevoflurane preconditioning on cardiomyocyte apoptosis following myocardial ischemia/reperfusion in rats

Role of Mitochondrial ATP-sensitive Potassium Channel-Mediated PKC-ε in Delayed Protection Against Myocardial Ischemia/reperfusion Injury in Isolated Hearts of Sevoflurane-Preconditioned Rats

Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.

Effects of Sevoflurane Postconditioning on the Expressions of AKT/GSK3β/mTOR During Ischemia-Reper-fusion in Rat Hearts

Activation of Akt and Cardioprotection Against Reperfusion Injury Are Maximal with Only Five Minutes of Sevoflurane Postconditioning in Isolated Rat Hearts

Role of Reperfusion Injury Salvage Kinase Signaling Pathway in Reduction of Myocardial Ischemia-Reperfusion Injury by Sevoflurane Postconditioning in Rats

Effects of Sevoflurane Preconditioning and Postconditioning on Rat Myocardial Stunning in Ischemic Reperfusion Injury

Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signals.

Effects of Sevoflurane Delayed Preconditioning on Caspase Recruitment Domain Expression During Myocardial Ischemia-Reperfusion in Rats